Compare GDTC & NOTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GDTC | NOTE |
|---|---|---|
| Founded | 2018 | 2013 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.8M | 27.5M |
| IPO Year | 2023 | N/A |
| Metric | GDTC | NOTE |
|---|---|---|
| Price | $1.55 | $1.56 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $29.25 |
| AVG Volume (30 Days) | 37.7K | ★ 248.4K |
| Earning Date | 04-24-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $573,193.00 | ★ $102,673,000.00 |
| Revenue This Year | $5.37 | N/A |
| Revenue Next Year | N/A | $0.55 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 63.03 | N/A |
| 52 Week Low | $1.38 | $1.53 |
| 52 Week High | $4.05 | $24.36 |
| Indicator | GDTC | NOTE |
|---|---|---|
| Relative Strength Index (RSI) | 42.83 | 28.50 |
| Support Level | $1.49 | $1.63 |
| Resistance Level | $1.63 | $1.73 |
| Average True Range (ATR) | 0.13 | 0.15 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 27.03 | 7.84 |
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
FiscalNote Holdings Inc is a provider of world-wide policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With its analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.